Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 707.1%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 707.09% |
Universe Pharmaceuticals (UPC) | 618.49% |
Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | 602.5% |
Dominari (DOMH) | 482.99% |
Abits (ABTS) | 442.32% |
Yoshiharu Global (YOSH) | 438.18% |
CervoMed (CRVO) | 346.25% |
Oncology Institute (TOI) | 305.23% |
Jiuzi (JZXN) | 255.71% |
Zoomcar (ZCAR) | 210.95% |
MicroAlgo (MLGO) | 199.57% |
Rapid Micro Biosystems (RPID) | 190.11% |
Neuronetics (STIM) | 183.03% |
Junee Limited Ordinary Shares (JUNE) | 152.28% |
Xunlei Ltd Adr (XNET) | 147.55% |
Root (ROOT) | 142.61% |
Chimerix (CMRX) | 142.17% |
Trivago (TRVG) | 140.64% |
VivoPower International (VVPR) | 138.52% |
Reborn Coffee (REBN) | 136.84% |
Niu Technologies (NIU) | 135.56% |
Biomerica (BMRA) | 129% |
Alpha Technology Group Limited Ordinary Shares (ATGL) | 124.48% |
Digital Turbine (APPS) | 109.77% |
Lottery, Inc Common Stock (LTRY) | 109.66% |
